Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 436,521 | 1,467,626 | 1,007,292 | 654,230 | 327,214 |
| Accounts payable and accrued liabilities | -421,973 | -1,225,968 | -880,104 | -600,174 | -324,067 |
| Other Working Capital | -218 | 194,572 | 91,048 | 35,703 | -10,863 |
| Other Operating Activity | -16,507 | -244,650 | -129,807 | -56,328 | -4,925 |
| Operating Cash Flow | $-2,177 | $191,580 | $88,429 | $33,431 | $-12,641 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,907 | 200,026 | 192,694 | -5,353 | 23,732 |
| PPE Investments | -19,045 | -60,595 | -45,938 | -27,270 | -10,636 |
| Net Acquisitions | -17,106 | -387,673 | -2,496 | -2,496 | -860 |
| Purchase Sale Intangibles | -675 | -2,075 | -2,075 | -2,075 | -675 |
| Other Investing Activity | -6,720 | -6,187 | -4,202 | -863 | -378 |
| Investing Cash Flow | $-34,964 | $-254,429 | $140,058 | $-35,982 | $11,858 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 24 | N/A | N/A | N/A |
| Debt Repayment | -2,190 | -17,720 | -488 | -305 | -123 |
| Common Stock Issued | 3,688 | 11,580 | 9,109 | 6,162 | 4,147 |
| Other Financing Activity | 1,291 | -1,334 | 3,969 | 3,498 | 3,241 |
| Financing Cash Flow | $2,789 | $-7,450 | $12,590 | $9,355 | $7,265 |
| Exchange Rate Effect | 2,068 | 8,456 | 8,108 | 1,992 | 225 |
| Beginning Cash Position | 161,764 | 223,607 | 223,607 | 223,607 | 223,607 |
| End Cash Position | 129,480 | 161,764 | 472,792 | 232,403 | 230,314 |
| Net Cash Flow | $-32,284 | $-61,843 | $249,185 | $8,796 | $6,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,177 | 191,580 | 88,429 | 33,431 | -12,641 |
| Capital Expenditure | -19,045 | -60,595 | -45,938 | -27,270 | -10,636 |
| Free Cash Flow | -21,222 | 130,985 | 42,491 | 6,161 | -23,277 |